- Posted by cloudpharm
- On 06/07/2015
Dr. Matsoukas, (MSc, PhD), has been employed both in industry and academia. He has served as CEO of a spin-off drug development company (Eldrug SA), which has equipped him with strong collaborative skills, group management expertise and strategic decision-making. He has always been searching for novel drug targets, and has undertaken a series of projects, from basic academic research (drug design) to industrial preclinical investigation of novel compounds. Academically, he has worked with several groups in Europe on the discovery and identification of drug leads against several drug targets.